112
Participants
Start Date
April 7, 2015
Primary Completion Date
June 26, 2017
Study Completion Date
December 25, 2020
Talimogene Laherparepvec
The initial dose of talimogene laherparepvec is up to 4.0 mL of 10\^6 PFU/mL. Subsequent doses of talimogene laherparepvec are up to 4.0 mL of 10\^8 PFU/mL.
Research Site, Brussels
Research Site, Budapest
Research Site, Vienna
Research Site, Budapest
Research Site, Brussels
Research Site, Liège
Research Site, Debrecen
Research Site, Salzburg
Research Site, Szeged
Research Site, Pécs
Research Site, Athens
Research Site, Marseille
Research Site, Athens
Research Site, Donostia / San Sebastian
Research Site, Milan
Research Site, Bergamo
Research Site, Pátrai
Research Site, Madrid
Research Site, Madrid
Research Site, Hanover
Research Site, Nantes
Research Site, Essen
Research Site, Valencia
Research Site, Siena
Research Site, Thessaloniki
Research Site, Frankfurt am Main
Research Site, Heidelberg
Research Site, Heraklion - Crete
Research Site, Paris
Research Site, Salt Lake City
Research Site, Poitiers
Research Site, Boulogne-Billancourt
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Amsterdam
Research Site, Groningen
Research Site, Konin
Research Site, Warsaw
Research Site, Badalona
Research Site, Barcelona
Research Site, London
Research Site, Metropolitan Borough of Wirral
Lead Sponsor
Amgen
INDUSTRY